1. Akaike N, Hattori K, Inomata N, Oomura Y. Gamma-aminobutyric acid- and pentobarbitone-gated chloride currents in internally perfused frog sensory neurones. J Physiol 1985;360:367-386.

2. Akaike N, Maruyama T, Tokutomi N. Kinetic properties of the pentobarbitone-gated chloride current in frog sensory neurones. J Physiol 1987;394:85-98.

3. Amin J, Weiss DS. GABAA receptor needs two homologous domains of the beta subunit for activation by GABA but not by pentobarbital. Nature 1994;366:565-569.

4. Angelotti TP, Macdonald RL. Assembly of GABAA receptor subunits: 11 and 112S subunits produce unique ion channels with dissimilar single-channel properties. J Neurosci 1993;13:1429-1440.

5. Asano T, Ogasawara N. Chloride-dependent stimulation of GABA and benzodiazepine receptor binding by barbiturates. Brain Res 1981;255:212-216.

6. Barker JL, Ransom BR. Pentobarbitone pharmacology of mammalian central neurones grown in tissue culture. J Physiol 1978;280:355-372.

7. Bormann J, Hamill OP, Sakmann B. Mechanism of anion permeation through channels gated by glycine and -aminobutyric acid in mouse cultured spinal neurones. J Physiol 1987;385:243-286.

8. Butler TC. The delay in onset of action of intravenously injected anesthetics. J Pharmacol 1954;74:118-128.

9. Chang Y, Wang R, Barot S, Weiss DS. Stoichiometry of a recombinant GABAA receptor. J Neurosci 1996;16:5415-5424.

10. Cole-Harding S, de Wit H. Self-administration of pentobarbital in light and moderate alcohol drinkers. Pharmacol Biochem Behav 1992;43:563-569,.

11. Curtis DR, Lodge D. Pentobarbitone enhancement of the inhibitory action of GABA. Nature 1977;270:543-544.

12. Davies PA, Hanna MC, Hales TG, Kirkness EF. Insensitivity to anaesthetic agents conferred by a class of GABAA receptor subunit. Nature 1997;385:820-824.

13. de Wit H, Griffiths R. Testing the abuse liability of anxiolytic and hypnotic drugs in humans. Drug Alcohol Depend 1991;28:83-111.

14. Downes H, Perry RS, Ostlund RE, Karler R. A study of the excitatory effects of barbiturates. J Pharmacol Exp Ther 1970;175:692-699.

15. Eccles JC, Malcolm JL. Dorsal root potentials of the spinal cord. J Neurophysiol 1946;9:139-160.

16. Eccles JC, Schmidt RF, Willis WD. Pharmacological studies on presynaptic inhibition. J Physiol 1963;168:500-530.

17. ffrench-Mullen JMH, Barker JL, Rogawski MA. Calcium current block by (-) pentobarbital, phenobarbital and CHEB but not by (+) pentobarbital in acutely isolated hippocampal CA1 neurons: comparison with effects on GABA-activated Cl- current. J Neurosci 1993;13:3211-3221.

18. Franks NP, Lieb WR. Molecular and cellular mechanisms of general anaesthesia. Nature 1994;367:607-614.

19. Frenkel C, Duch DS, Urban BW. Molecular actions of pentobarbital isomers on sodium channels from human brain cortex. Anesthesiology 1990;72:640-649.

20. Gibbons SJ, Nuñez R, Mazé G, Harrison NL. Inhibition of a fast inwardly rectifying potassium conductance by barbiturates. Anesth Analg 1996;82:1242-1246.

21. Griffiths RR, Bigelow GE, Liebson I, Kaliszak JE. Drug preference in humans: double-blind choice comparison of pentobarbital, diazepam and placebo. J Pharmacol Exp Ther 1980;215:649-661.

22. Gross RA, Macdonald RL. Differential actions of pentobarbitone on calcium current components of mouse sensory neurones in culture. J Physiol 1988;405:187-203.

23. Günther U, Benson J, Benke D, et al. Benzodiazepine-insensitive mice generated by targeted disruption of the 2 subunit gene of -aminobutyric acid type A receptors. Proc Natl Acad Sci USA 1995;92:7749-7753.

24. Hadingham KL, Wingrove P, Le Bourdelles B, Palmer KJ, Ragan CI, Whiting PJ. Cloning of cDNA sequences encoding human 2 and 5-aminobutyric acidA receptor subunits and characterization of the benzodiazepine pharmacology of recombinant 1-, 2-, 3-, and 5-containing human -aminobutyric acidA receptors. Mol Pharmacol 1993a;43:970-975.

25. Hadingham KL, Wingrove PB, Wafford KA, et al. The role of the beta subunit in determining the pharmacology of GABAA receptors. Mol Pharmacol 1993b;44:1211-1218.

26. Harrison NL. Pentobarbitone as an excitatory amino acid antagonist in slices of rat cerebral cortex. J Physiol 1985;360:38P.

27. Harrison NL, Simmonds MA. Two distinct interactions of barbiturates and chlormethiazole with the GABAA receptor complex in rat cuneate nucleus in vitro. Br J Pharmacol 1983;80:387-394.

28. Ho IK, Harris RA. Mechanism of action of barbiturates. Ann Rev Pharmacol Toxicol 1981;21: 83-111.

29. Hobbs WR, Rall TW, Verdoorn TA. Hypnotics and sedatives; ethanol. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics, ninth edition. Hardman JC, Limbird LE, eds. New York: McGraw-Hill, 1996;361-396.

30. Homanics GE, DeLorey TM, Firestone LL, et al. Mice devoid of -aminobutyrate type A receptor 3 subunits have epilepsy, cleft palate, and hypersensitive behavior. Proc Nat Acad Sci USA 1997;94:4143-4148.

31. Jaffe JH, Jaffe FK. Historical perspectives on the use of subjective effects measures in assessing the abuse potential of drugs. In: Testing for abuse liability of drugs in humans. Fishman MW, Mello NK, eds. NIDA Research Monograph 92, 1989;43-72.

32. Koltchine VV, Ye Q, Finn SE, Harrison NL. Chimeric GABAA /glycine receptors: expression and barbiturate pharmacology. Neuropharmacology 1996;35:1445-1456.

33. Krasowski MD, O'Shea SM, Rick CEM, et al. subunit influences GABAA receptor modulation by propofol. Neuropharmacology 1997, 36:941-949

33a. Krasowski M.D., Koltchine V.V., Rick C.E.M., Ye Q., Finn S.E., and Harrison N.L. (1998) Propofo and isoflurane have different sites of action on the g-aminobutyri acid-A receptor. Molecular Pharmacology, 53, 530-538.

34. Levitan ES, Blair LA, Dionne VE, Barnard EA. Biophysical and pharmacological properties of cloned GABAA receptor subunits expressed in Xenopus oocytes. Neuron 1988;1:773-781.

35. Macdonald RL, Rogers CJ, Twyman RE. Barbiturate regulation of kinetic properties of the GABAA receptor channel of mouse spinal neurones in culture. J Physiol 1989;417:483-500.

36. Macdonald RL, McLean MJ. Cellular bases of barbiturate and phenytoin anticonvulsant drug action. Epilepsia 1982;23(Suppl 1):S7-S18.

37. Marszalec W, Narahashi T. Use-dependent pentobarbital block of kainate and quisqualate currents. Brain Res 1993;608:7-15.

38. McCormick D. GABA as an inhibitory neurotransmitter in human cerebral cortex. J Neurophysiol 1989;62:1018-1027.

39. Mendelson WB. The use and misuse of sleeping pills. New York: Plenum Press, 1980;63-84.

40. Mendelson WB. Human sleep: Research and clinical care. New York: Plenum Press, 1987;81-106.

41. Mendelson WB, Rich CL. Sedatives and suicide: the San Diego study. Acta Psychiatr Scand 1993;88:337-341.

42. Mendelson WB, Thompson C, Franko T. Adverse reactions to sedative/hypnotics: three years' experience. Sleep 1996;19:702-706.

43. Natell S, Wang ZG, Matthews C. Direct electrophysiological effects of pentobarbital at concentrations achieved during general anesthesia. Am J Physiol 1990;259:1743-1751.

44. National Institute on Drug Abuse. National survey results on drug use from the Monitoring the future study. Rockville, MD: USDHHS Printing Office, 1995.

45. Nicoll RA, Eccles JC, Oshima T, Rubia F. Prolongation of hippocampal inhibitory postsynaptic potentials by barbiturates. Nature 1975;258:625-627.

46. Olsen R.W. and Snowman A.M. (1982) Chloride-dependent enhancement by barbituates of g-aminobutyric acid receptor binding. J. Neurosci., 2, 1812-1823.

47. Olsen R.W. and Tobin A.J. (1990) Molecular biology of GABAA receptors. FASEB J., 4, 1469-1480.

48. Pancrazio, J.J., Frazer M.J. and Lynch C. III (1993) Barbiturate anesthetics depress the resting K+ conductance of myocardium. J. Pharmacol. Exp. Ther., 265, 358-365.

49. Polc P. (1988) Electrophysiology of benzodiazepine receptor ligands: multiple mechanisms and sites of action. Prog. Neurobiol., 31, 349-423.

50. Pritchett D.B., Sontheimer H., Gorman C.M., Kettenmann H., Seeburg P.H. and Schofield P.R. (1988a) Transient expression shows ligand gating and allosteric potentiation of GABA A receptor subunits. Science, 242, 1306-1308.

51. Pritchett D.B., Sontheimer H., Shivers B.D., Ymer S., Kettenmann H., Schofield P.R. and Seeburg P.H. (1988b) Importance of a novel GABA A receptor subunit for benzodiazepine pharmacology. Nature, 338, 582-585.

52. Ragsdale D.S., McPhee J. C., Scheuer T. and Catterall W. A. (1994) Molecular determinants of state-dependent block of Na+ channels by local anesthetics. Science, 265, 1724-1728.

53. Raines A., Blake G.J., Richardson B. and Gilbert M.B. (1979) Differential selectivity of several barbituates on experimental seizures and neurotoxicity in the mouse. Epilepsia, 20, 105-113.

54. Rausch, R. and Risinger, M. (1990) Intracarotid sodium amobarbital procedure. Neuromethods, Vol 17: Neuropsychology. Eds A.A. Boulton, G.B. Baker, M. Hiscock. The Human Press Inc., Clifton NJ.

55. Richards C.D. (1972) On the mechanism of barbiturate anaesthesia. J. Physiol., 227, 749-767.

56. Richards C.D. and Smaje J.C. (1976) Anaesthetics depress the sensitivity of cortical neurones to L-glutamate. Br. J. Pharmac., 59, 347-357.

57. Roache J.D. and Griffiths R.R. (1985) Comparison of triazolam and pentobarbital: performance impairment, subjective effects and abuse liability. J. Pharmacol. Exp. Therapeut. 234, 120-133.

58. Roth S.H., Forman S.A., Braswell L.M. and Miller K.W. (1989) Actions of pentobarbital enantiomers on nicotinic cholinergic receptors. Mol. Pharmacol., 36, 874-880.

59. Sanna E., Garau F. and Harris R.A. (1995) Novel properties of homomeric b1 g-aminobutyric acid type A receptors: actions of the anesthetics propofol and pentobarbital . Mol. Pharmacol., 47, 213-217.

60. Scholfield C.N. (1980) Potentiation of inhibition by general anaesthetics in neurones of the olfactory cortex in vitro. Pflugers Arch., 383, 249-255.

61. Schofield P.R., Darlison M.G., Fujita N., Burt D.R., Stephenson F.A., Rodriguez H., Rhee L.M., Ramachandran J., Reale V., Glencorse T.A., Seeburg P.H. and Barnard E.A. (1987). Sequence and functional expression of the GABAA receptor shows a ligand-gated receptor superfamily. Nature, 328, 221-227.

62. Smith G.B. and Olsen R.W. (1995) Functional domains of GABAA receptors. Trends in Neurosciences, 16, 162-167.

63. Snyder, P.J., Novelly, R.A. and Harris, L.J. (1990) Mixed speech dominance in the intracarotid sodium amytal procedure: Validity and criteria issues. J. Clin. Exptl. Neuropsych., 12, 629-643.

64. Stephenson F.A., Duggan M.J. and Pollard S. (1990) The g2 subunit is an integral component of the g-aminobutyric acidA receptor but the a1 polypeptide is the principal site of the agonist benzodiazepine photoaffinity labeling reaction. J. Biol. Chem., 265, 21160-21165.

65. Study R.E. and Barker J.L. (1981) Diazepam and (-)pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of g-aminobutyric acid responses in cultured central neurons. Proc. Natl. Acad. Sci. U.S.A., 78, 7180-7184.

66. Substance Abuse and Mental Health Services Administration (1995) National Household Survey on Drug Abuse: Population Estimates. US Govt Printing Office, Washington DC.

67. Teichberg V.I., Tal N., Goldberg O. and Luini A. (1984) Barbiturates, alcohols and the CNS excitatory neurotransmission: specific effects on the kainate and quisqualate recepotrs. Brain Res., 291, 285-292.

68. Thompson S.A., Whiting P.J. and Wafford K.A. (1996) Barbiturate interactions at the human GABAA receptor: dependence upon receptor subunit composition. Br. J. Pharmacol., 117, 521-527.

69. Twyman R.E., Rogers C.J. and Macdonald R.L. (1989) Differential regulation of g-aminobutyric acid receptor channels by diazepam and pentobarbital. Ann. Neurol, 25, 213-220.

70. Verdoorn T. A., Draguhn A., Ymer S., Seeburg P.H. and Sakmann B. (1990) Functional properties of recombinant rat GABAA receptors depend upon subunit composition. Neuron, 4, 919-928.

71. Wada, J. (1949) A new method for the determination of the side of cerebral speech dominance. A preliminary report on the intracarotid injection of sodium amytal in man. Medicine and Biology 14, 221-222 (Japanese).

72. Weakly J.N. (1969) Effects of barbiturates on ‘quantal' synaptic transmission in spinal motoneurones. J. Physiol., 204, 63-76.

73. Wieland H., Lyddens H. and Seeburg P.H. (1992) A single histidine residue is essential for benzodiazepine binding. J. Biol. Chem., 257, 1426-1429.

74. Woods J.H., Katz J.L. and Winger G. (1987) Abuse liability of benzodiazepines. Pharmacol. Rev. 39, 251-419.

75. Xu M. and Akabas M.H. (1996) Identification of channel-lining residues in the M2 membrane-spanning segment of the GABAA receptor a1 subunit. J. Gen. Physiol., 107, 195-205.

76. Zhang J. F., Randall A.D., Ellinor P.T., Horne W.A., Sather W.A., Tanabe T., Schwarcz T. L. and Tsien R. W. (1993) Distinctive pharmacology and kinetics of cloned neuronal Ca2+ channels and their possible counterparts in mammalian CNS neurons. Neuropharmacoloy, 32: 1075-1089.